At 21.5x earnings and 19.9x forward earnings, PG trades like a premium defensive compounder, yet the PEG Forward of 8.4 screams that growth is not keeping pace with valuation. The Altman Z-Score of 5.3 indicates very low bankruptcy risk, so balance sheet distress is not the issue; this is a stability story, not a turnaround. However, with EPS at 14.9 and next year’s estimate at $6.90, the earnings trajectory looks inconsistent relative to the multiple investors are paying. This is not a distressed mispricing—it’s a quality franchise priced for durability, but arguably expensive relative to its implied growth rate. The market is paying up for safety, not acceleration.